Covered recipient · General Payments record
THOMAS K MORGAN
Physician Assistants & Advanced Practice Nursing Providers Physician Assistant Medical
General Payments · PY2023–2024
$774.70
- Reported across 42 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $495.02 | 27 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| PFIZER INC. | $97.06 | 5 |
| Novo Nordisk AS | $96.79 | 6 |
| ABBVIE INC. | $79.06 | 5 |
| Lilly USA, LLC | $46.90 | 2 |
| Acerta Pharma LLC | $43.49 | 2 |
| Amgen Inc. | $41.78 | 2 |
| Otsuka America Pharmaceutical, Inc. | $23.94 | 1 |
| Janssen Pharmaceuticals, Inc | $20.39 | 1 |
| GlaxoSmithKline, LLC. | $15.50 | 1 |
| NOVARTIS PHARMACEUTICALS CORPORATION | $15.38 | 1 |
| Astellas Pharma US Inc | $14.73 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (27)
Sorted by paying entity, then date · as published by CMS
Program year 2024 2023
Record-level detail is published for PY2024; earlier years are summarised in
“By program year”.
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $14.37 | 02/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107693094 | CMS |
| ABBVIE INC. | $18.86 | 05/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107693096 | CMS |
| ABBVIE INC. | $17.70 | 06/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107693098 | CMS |
| ABBVIE INC. | $14.79 | 10/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107693100 | CMS |
| ABBVIE INC. | $13.34 | 11/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107693102 | CMS |
| Amgen Inc. | $23.68 | 02/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117634197 | CMS |
| Amgen Inc. | $18.10 | 03/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117634199 | CMS |
| Astellas Pharma US Inc | $14.73 | 08/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139536724 | CMS |
| AstraZeneca Pharmaceuticals LP | $28.72 | 03/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104383149 | CMS |
| AstraZeneca Pharmaceuticals LP | $14.77 | 12/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104651265 | CMS |
| GlaxoSmithKline, LLC. | $15.50 | 03/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116388790 | CMS |
| Janssen Pharmaceuticals, Inc | $20.39 | 11/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1078241227 | CMS |
| Lilly USA, LLC | $19.45 | 02/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135969272 | CMS |
| Lilly USA, LLC | $27.45 | 03/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135895739 | CMS |
| Novartis Pharmaceuticals Corporation | $15.38 | 07/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1087131852 | CMS |
| Novo Nordisk Inc | $16.02 | 01/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100395894 | CMS |
| Novo Nordisk Inc | $15.06 | 02/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100466668 | CMS |
| Novo Nordisk Inc | $13.62 | 03/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100356998 | CMS |
| Novo Nordisk Inc | $19.76 | 04/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100470294 | CMS |
| Novo Nordisk Inc | $16.39 | 05/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100345498 | CMS |
| Novo Nordisk Inc | $15.94 | 08/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100244867 | CMS |
| Otsuka America Pharmaceutical, Inc. | $23.94 | 01/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1119143579 | CMS |
| PFIZER INC. | $20.75 | 02/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131123143 | CMS |
| PFIZER INC. | $21.59 | 03/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131288511 | CMS |
| PFIZER INC. | $22.41 | 06/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131632113 | CMS |
| PFIZER INC. | $17.65 | 07/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131753026 | CMS |
| PFIZER INC. | $14.66 | 11/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1132106646 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2023, 2024
- Source files
- Dataset page · Bulk file · PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.